Cannabis CannTrust’s low valuation non-compliant with NYSE listing rules The troubled producer's market value has fallen below the required average closing price of US$1.00 per share over a consecutive 30 trading-day period Nick LabaFebruary 28, 2020
Canada Year in review: Top 8 cannabis stories of 2019 It may have been a sobering year for the legal weed industry, but cannabis still made major waves in society, politics and science in... Jared GnamDecember 31, 2019
Canada Hexo shares on rollercoaster ride after company reveals unlicensed cannabis Hexo's share price recovered after reports surfaced that Health Canada said it was satisfied with the company's corrective actions Jared GnamNovember 19, 2019
Canada Aphria Obtains Long-Awaited Cultivation Licence, Doubles Production Capacity The Canadian cultivator finally secures a licence for its Leamington, Ont. greenhouse Nick LabaNovember 4, 2019
Canada Winnipeg-based Pot Producer Bonify Gets Health Canada Sales Licence Reinstated "A landmark moment" for the Canadian cannabis sector which could also serve as a precedent for troubled CannTrust, says Bonify interim CEO Jared GnamOctober 24, 2019
Canada CannTrust to Destroy $77 Million Worth of Cannabis to Regain Compliance CannTrust will destroy $77 million of illegally grown cannabis to get its growing and selling licenses back, which were suspended by Health Canada in... Michelle GamageOctober 15, 2019